The HPV vaccine is a key tool in the prevention of cervical cancer and has shown great promise in reducing both the incidence ...

An important challenge associated with vaccine coadministration studies is the need to test multiple hypotheses ... initially S− subjects with anti-HPV antibodies ≥20, 16, 20 and 24 mMU ...

If you didn’t receive the human papillomavirus (HPV) vaccine when you were a pre-teen/teenager, you may want to consider getting it as an adult, especially if you’re recently divorced or widowed and ...

Researchers at a University of Michigan lab have developed a “first-of-its-kind” blood test to detect head and neck cancers ...

Developed at the University of Michigan, MyHPVscore is a highly accurate blood test that can detect human papilloma virus-related head and neck cancer by measuring fragments of tumor DNA in a ...

Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

The study, which tracked associations between erectile function, ... Tuberculosis Disease Intensifies HIV Antibody Response in People With HIV May 9, 2023 — New research found that people living ...

Jan. 2, 2025 — Scientists have developed a nanopore-based tool that could help diagnose illnesses much faster and with greater precision than current tests allow, by capturing signals from ...

One area that Vaccitech has developed a potential therapeutic is with its VTP-200 program, which being investigated against human papillomavirus (HPV) at the phase I/II stage. HPV infection is ...

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT) in combination with docetaxel is to be the first prostate cancer treatment to be made ...